Data / Research funding / Missouri / Midwest Research Institute
Midwest Research Institute: 13 NIH awards ($70M), fiscal years 2021 to 2026
Midwest Research Institute in Kansas City, MO is funded under 13 NIH awards ($70M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- HKQHNFKNKL15
- State
- Missouri
Awards
13 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE | NIH | National Cancer Institute | 2023 to 2025 | $22,579,077 | September 22, 2025 | September 21, 2027 | reporter.nih.gov | |
| Chemistry Services for the National Toxicology Program-Per and polyfluorinated substances (PFAS) | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $21,117,591 | July 18, 2014 | January 17, 2026 | AILLON, KRISTIN | reporter.nih.gov |
| CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT | NIH | National Cancer Institute | 2021 to 2022 | $9,504,731 | July 1, 2019 | February 28, 2023 | ALLEN, CHARLES | reporter.nih.gov |
| SLAUGENHAUPT-MGH DMFP FOR BPN36964 (PTC680) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $5,064,229 | September 19, 2024 | September 18, 2029 | PENNY, BRIAN | reporter.nih.gov |
| MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,608,548 | January 1, 2023 | December 31, 2023 | COFFIN, JEANETTE | reporter.nih.gov |
| Mycobacterium Tuberculosis (MTB) Quality Assessment Program (TBQA) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,397,377 | November 17, 2024 | November 16, 2025 | OLINGER, GENE GARRARD | reporter.nih.gov |
| Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,829,809 | December 1, 2024 | November 30, 2025 | KENNEDY, MICHELLE | reporter.nih.gov |
| PROCESS DEVELOPMENT OF TELACEBEC FOR TUBERCULOSIS | NIH | National Institute on Drug Abuse | 2024 to 2025 | $741,892 | September 30, 2024 | September 29, 2026 | SLADE, DESMOND | reporter.nih.gov |
| Drug Shelf Life Testing | NIH | National Cancer Institute | 2021 to 2023 | $695,142 | February 1, 2018 | July 31, 2023 | WHITE, JONATHAN | reporter.nih.gov |
| ANALYTICAL METHOD DEVELOPMENT, VALIDATION AND STABILITY STUDY OF ORC-13661 | NIH | National Institute on Drug Abuse | 2023 to 2024 | $309,251 | September 29, 2022 | June 30, 2027 | SLADE, DESMOND | reporter.nih.gov |
| THE OBJECTIVE OF THIS TASK ORDER IS TO PERFORM DEVELOPMENTAL STUDIES OF ISOTOPE-SPECIFIC 2-KETOGLUTARIC ACID. | NIH | National Cancer Institute | 2021 to 2023 | $118,117 | September 13, 2021 | July 12, 2023 | WHITE, JONATHAN | reporter.nih.gov |
| INITIAL FUNDING, RFP #N02-CM-37002-05, DTP-13-015, 02/01/2013 - 01/31/2014, SHE | NIH | National Cancer Institute | 2023 to 2024 | $8,691 | February 1, 2013 | January 31, 2018 | WHITE, PHD, JONATHAN | reporter.nih.gov |
| Task Area E: NIAID Preclinical Services for AMR Diagnostics Development | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $7,000 | June 20, 2023 | June 19, 2030 | GIRARD, YVETTE | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 6 | $15,477,912 | 0 | $0 |
| 2024 | 8 | $15,756,099 | 0 | $0 |
| 2023 | 10 | $16,207,883 | 0 | $0 |
| 2022 | 7 | $12,877,778 | 0 | $0 |
| 2021 | 6 | $9,661,783 | 0 | $0 |
Topics of its NIH awards
- Infectious Diseases
- Translational Research
- Cancer
- Emerging Infectious Diseases
- Orphan Drug
- Rare Diseases
- Prevention
- Biodefense and Related Countermeasures
- HIV/AIDS
- Immunization
- Tuberculosis
- Vaccine Related
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.